FAM161A expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.418800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.626000E-01
Normal-vs-Stage2
7.641200E-01
Normal-vs-Stage3
2.900100E-02
Normal-vs-Stage4
2.424400E-01
Stage1-vs-Stage2
1.201040E-01
Stage1-vs-Stage3
7.206200E-02
Stage1-vs-Stage4
6.184600E-01
Stage2-vs-Stage3
1.242020E-01
Stage2-vs-Stage4
3.612000E-02
Stage3-vs-Stage4
2.105700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.047800E-01
Normal-vs-AfricanAmerican
6.588400E-01
Normal-vs-Asian
3.929200E-01
Caucasian-vs-AfricanAmerican
5.969600E-01
Caucasian-vs-Asian
6.714200E-02
AfricanAmerican-vs-Asian
6.371800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.860400E-01
Normal-vs-Female
8.957600E-01
Male-vs-Female
6.374400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.624800E-01
Normal-vs-Age(41-60Yrs)
7.830600E-01
Normal-vs-Age(61-80Yrs)
9.977400E-01
Normal-vs-Age(81-100Yrs)
5.930200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.855400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.803800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.527200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.503600E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.445600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.370200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.672400E-01
Normal-vs-Daily Drinker
9.105600E-01
Normal-vs-Weekly Drinker
8.411000E-01
Normal-vs-Occasional Drinker
3.968800E-01
Normal-vs-Social Drinker
3.845400E-01
Non Drinker-vs-Daily Drinker
4.323600E-01
Non Drinker-vs-Weekly Drinker
1.545440E-01
Non Drinker-vs-Occasional Drinker
1.307770E-01
Non Drinker-vs-Social Drinker
1.845030E-01
Daily Drinker-vs-Weekly Drinker
6.061400E-01
Daily Drinker-vs-Occasional Drinker
3.258800E-01
Daily Drinker-vs-Social Drinker
3.424200E-01
Weekly Drinker-vs-Occasional Drinker
5.852800E-01
Weekly Drinker-vs-Social Drinker
5.098600E-01
Occasional Drinker-vs-Social Drinker
8.158200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.429600E-01
Normal-vs-Grade 2
1.113750E-01
Normal-vs-Grade 3
1.046220E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.686210E-01
Grade 1-vs-Grade 3
3.601000E-01
Grade 1-vs-Grade 4
4.429600E-01
Grade 2-vs-Grade 3
9.756400E-02
Grade 2-vs-Grade 4
1.113750E-01
Grade 3-vs-Grade 4
1.046220E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.141400E-01
Normal-vs-NonDiabetic
8.899400E-01
Diabetic-vs-NonDiabetic
1.254370E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.618600E-01
Normal-vs-NoPancreatitis
9.491200E-01
Pancreatitis-vs-NoPancreatitis
1.402760E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.164200E-01
Normal-vs-N1
8.256000E-01
N0-vs-N1
1.621380E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.683200E-01
Normal-vs-TP53-NonMutant
6.207400E-01
TP53-Mutant-vs-TP53-NonMutant
7.003900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
